Latest News Nine Drug Formularies In Canada List Evenity® For Reimbursement For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk Of Fracture April 3, 2024 Amgen Canada has […]
Latest News Dr. Angela Man-Wei Cheung ISCD 2024 Board Announcement April 19, 2024 The International Society for Clinical Densitometry (ISCD) is the leading membership organization for professionals working to assess, […]
Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]
It is well known that calcium is a necessary nutrient because it plays an essential role in human health, not only for bone development but also for the heart, muscle […]
Fracture Liaison Service (FLS) FLS: MAKE YOUR FIRST BREAK YOUR LAST! A Fracture Liaison Service (FLS) is a specific model of care where a coordinator pro-actively identifies fracture patients, on […]
Latest News PHAC Osteoporosis Key Findings August 18, 2021 Osteoporosis Canada has been working closely with the Public Health Agency of Canada (PHAC) over the past few years assisting in […]
Bubl Fashion Feb 7th, 2019 Introducing a new collection from fashion designer, David Dixon, working in partnership with Osteoporosis Canada. LEARN MORE Living with the Disease Get valuable insight into […]
Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]
BC Advocacy Osteoporosis Canada with the BCCOP and MedAccess BC are working together to advocate for British Columbians at high risk of osteoporotic fracture to have their medication/treatments publicly funded. […]
